It is estimated that there are almost half a million women living with or beyond a breast cancer diagnosis in the UK, often referred to as the breast cancer survivor population. We report on the setting up of a dedicated breast cancer and menopause symptoms service (BCMS), and present ...
We aimed to estimate and externally validate a new UK-specific prognostic model for predicting the long-term risk of a first recurrent event (local recurrence, metastatic recurrence, or second primary breast cancer) in women diagnosed with early breast c
Find all the latest on breast cancer patients at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
We assessed health-related quality of life (symptoms of therapy/patient functioning/global health status), in APHINITY (pertuzumab/placebo, trastuzumab, and chemotherapy as adjuvant HER2-positive early breast cancer therapy). Patients received 1 year/18
Breast cancer is a disease characterized by the growth of malignant cells in the mammary glands. Breast cancer affects males and females, although women are about 100 times more likely to develop the disease than men.
A Clinical Decision Support System for Breast Cancer Patients 125 In the survival analysis field, the proportional hazard model, also known as Cox regression is widely used. Cox regression factorises dependence on time and the co- variates, where the hazard rate is modelled for each patient with...
Development of Postoperative Radiotherapy for Breast Cancer: UK Consensus Statements — a Model of Patient, Clinical and Commissioner Engagement?The objective of this work is to present commissioning procedures to clinically implement a three-dimensional (3D), image-based, treatment-planning system (TPS...
NewsEnhertu Approved in UK for Inoperable, Advanced Breast Cancer NewsPhase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC NewsTukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer NewsTrial Testing AL101 in TNBC Doses First Patient ...
Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, Coebergh JW (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41: 779–785 Article CAS PubMed Google Scholar...
Breast cancer: prostaglandins and patient survival. Br. J. Cancer 1989; 59, 260-75.Bennett A,Stamford IF,Berstock DA ,et al.Breast cancer: prostaglandins and patient survival.British Journal of Cancer. 1989Bennett A,Stamford IF,Berstock DA, et al.Breast cancer:prostaglandins and patient ...